You are here

580b57fcd9996e24bc43c53e   LinkedIn Logo 500x500   Facebook logo square   Iguana Trans cropped

event icon
17.10.19 - 18.10.19
BioCity, Nottingham NG1 1GF

A Biochemical Society Training Event


Designed and delivered by experts from industry and academia, this training event will provide a comprehensive overview of the pre-clinical drug discovery process. The workshop will focus on small molecule target identification and validation, hit-to-lead and lead optimisation, as well as on pre-clinical drug development and toxicology.

The programme will include lectures, case studies and group discussions, providing great networking opportunities and encouraging collaboration among delegates and speakers.

Programme Coordinators

  • Rick Davies, AstraZeneca
  • Jacqui Piner, GSK
  • John Unitt, Sygnature Discovery
  • Heather Wallace, University of Aberdeen
  • John Ladbury, University of Leeds
  • John Colyer, University of Leeds

The event is sponsored by the Royal Society of Chemistry, and supported by the British Pharmacological Society and the Royal Society of Biology


For further details and to register please visit the Biochemical Society website

Continuing Professional Development (CPD)

This event is approved by the Royal Society of Biology for purposes of CPD and may be counted as 48 CPD credits.

We use cookies: to perform functions such as login and account management; and to track usage with Google analytics to improve our website. To find out more about the cookies we use and how to delete them, see our cookie policy.   I accept cookies from this site.